NCT03104283View on ClinicalTrials.gov

Apatinib for the Elderly Advanced Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 5, 2017

Primary Completion Date

December 1, 2019

Study Completion Date

June 2, 2020

Conditions
Gastric Cancer
Interventions
DRUG

Apatinib

take apatinib orally until disease progression or appearance of unbearable toxicity

Trial Locations (5)

810000

Affiliated Hospital of Qinghai University, Xining

People's Hospital of Qinghai Province, Xining

Qinghai Red Cross Hospital, Xining

the Fifth People's Hospital of Qinghai Province, Xining

045000

Yangquan No.1 People's Hospital, Yangquan

All Listed Sponsors
lead

Affiliated Hospital of Qinghai University

OTHER

NCT03104283 - Apatinib for the Elderly Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter